Objective To explore the predictive value of fibrinogen to albumin ratio (FAR) for restenosis after percutaneous transluminal angioplasty (PTA) of the autologous arteriovenous fistula (AVF) in maintenance hemodialysis (MHD) patients. Methods A total of 101 MHD patients undergoing color Doppler ultrasound-guided PTA for the first time at the Department of Nephrology, the Affiliated Hospital of Guilin Medical University from January 2019 to December 2020 were included in this study. According to the presence or absence of restenosis after PTA in the follow-up period, they were divided into restenosis group and patency group. Clinical data were compared between the two groups. Receiver operating characteristic (ROC) curve was made to evaluate the predictive value of FAR for restenosis after PTA. The optimal cut-off value of FAR was determined by ROC curve analysis. The patients were then divided into low FAR group and high FAR group. Patency rate of the AVF in the two groups was analyzed by Kaplan-Meier curve. Cox proportional hazards regression model was used to explore the independent risk factors affecting restenosis after PTA. Results ①Multivariate Cox regression analysis showed that higher FAR (HR=2.455, 95% CI:1.299～4.639, P=0.006) was an independent risk factor for restenosis of the AVF after first PTA. ② The area under the curve (AUC) of FAR for predicting restenosis of the AVF after PTA was 0.735 (P<0.001, 95% CI:0.638～0.818). ③ Kaplan-Meier curve survival analysis showed that the patency rate after PTA was significantly lower in high FAR group than in low FAR group (log rank test, χ²=15.470, P<0.001). Conclusions ①Higher FAR is an independent risk factor for restenosis after PTA. ②FAR can be used as a biomarker to predict restenosis after the first PTA, useful for early prevention and treatment of restenosis after PTA.
[1]孔建平, 赵园园, 韩明月.维持性血液透析患者微炎症状态与动静脉内瘘失功的相关性分析[J].基层医学论坛, 2020, 24(34):4922-4924
[2]王爽, 毛英丽, 孙秀梅, 等.维持性血液透析患者自体动静脉内瘘失功的影响因素[J].中国医药, 2020, 15(3):423-426
[3]Viecelli A K, Mori T A, Roy-Chaudhury P, et al.The pathogenesis of hemodialysis vascular access failure and systemic therapies for its prevention: Optimism unfulfilled[J].Semin Dial, 2018, 31(3):244-257
[4]Ma S, Duan S, Liu Y, et al.Intimal Hyperplasia of Arteriovenous Fistula[J]. Ann Vasc Surg, 2022, 85:444-453.DOI:10.1016/j.avsg.2022.04.030.[J].Ann Vasc Surg, 2022, 85:444-453
[5]Portugaller R H, Kalmar P I, Deutschmann H.The eternal tale of dialysis access vessels and restenosis: are drug-eluting balloons the solution?[J].J Vasc Access, 2014, 15(6):439-447
[6]金其庄, 王玉柱, 叶朝阳, 等.中国血液透析用血管通路专家共识第版[J].中国血液净化, 2019, 18(06):365-381
[7]Manou-Stathopoulou S, Robinson E J, Harvey J J, et al.Factors associated with outcome after successful radiological intervention in arteriovenous fistulas: A retrospective cohort[J].J Vasc Access, 2019, 20(6):716-724
[8]Brahmbhatt A, Remuzzi A, Franzoni M, et al.The molecular mechanisms of hemodialysis vascular access failure[J].Kidney Int, 2016, 89(2):303-316
[9]Roy-Chaudhury P, Kelly B S, Miller M A, et al.Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts[J].Kidney Int, 2001, 59(6):2325-2334
[10]ilda? M B, ?ilda? S, K?seo?lu ? F K.The Relationship Between Neutrophil–Lymphocyte Ratio and Primary Patency of Percutaneous Transluminal Angioplasty in Hemodialysis Arteriovenous Fistula Stenosis When Using Conventional and Drug-Eluting Balloons[J].CardioVascular and Interventional Radiology, 2016, 39(12):1702-1707
[11]Zhu F, Yao Y, Ci H, et al.Predictive value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for primary patency of percutaneous transluminal angioplasty in hemodialysis arteriovenous fistula stenosis[J].Vascular, 2022, 30(5):920-927
[12]梁文琪, 蔡娅茜, 曹灵.纤维蛋白原白蛋白比值、全身炎症反应指数与慢性肾脏病患者肾功能进展的相关性研究[J].实用医院临床杂志, 2023, 20(01):119-124
[13]Kavitha S, Sridhar M G, Satheesh S.Periprocedural plasma fibrinogen levels and coronary stent outcome[J].Indian Heart J, 2015, 67(5):440-443
[14]Kaygin M A, Halici U, Aydin A, et al.The relationship between arteriovenous fistula success and inflammation[J].Ren Fail, 2013, 35(8):1085-1088
[15]马鹏跃, 吴永东, 黄凤璋, 等.血液透析患者动静脉内瘘晚期失功影响因素及其预测效能[J].山东医药, 2021, 61(12):81-84
[16]崔佳佳, 金卫东, 韩明磊, 等.纤维蛋白原白蛋白比值与急性心肌梗死患者介入治疗术后支架内再狭窄的关系[J].临床心血管病杂志, 2018, 34(11):1099-1103
[17]Zheng Q, Xie B, Xie X, et al.Predictors associated with early and late restenosis of arteriovenous fistulas and grafts after percutaneous transluminal angiography[J].Ann Transl Med, 2021, 9(2):132-
[18]Yang W, Zhang W, Ying H, et al.Two new inflammatory markers associated with disease activity score-28 in patients with rheumatoid arthritis: Albumin to fibrinogen ratio and C-reactive protein to albumin ratio[J]. International Immunopharmacology, 2018, 62:293-298.DOI:10.1016/j.intimp.2018.07.007.[J].International Immunopharmacology, 2018, 62:293-298
[19]Xia W, Li C, Yao X, et al.Prognostic value of fibrinogen to albumin ratios among critically ill patients with acute kidney injury[J].Intern Emerg Med, 2022, 17(4):1023-1031
[20]沃眉宏, 陆雨纯, 靳津, 等.纤维蛋白原前白蛋白比值和纤维蛋白原白蛋白比值与早期糖尿病肾脏疾病患者肾小管损伤的相关性研究[J].中国糖尿病杂志, 2021, 29(12):896-901
[21]马晶晶, 孙波, 郭翔, 等.及其联合应用对慢性阻塞性肺疾病急性加重的预测价值[J].解放军医学杂志, 2022, 47(06):599-606
[22]胡嘉铭, 季梦遥, 田山, 等.纤维蛋白原前白蛋白、纤维蛋白原白蛋白对炎症性肠病活动度诊断价值分析[J].中国临床医生杂志, 2022, 50(02):172-176
[23]Sun F, Tan Y A, Gao Q F, et al.Circulating fibrinogen to pre-albumin ratio is a promising biomarker for diagnosis of colorectal cancer[J].J Clin Lab Anal, 2019, 33(1):e22635-
[24]王尚, 刘源, 郑璐, 等.总胆红素、纤维蛋白原白蛋白比值及二者联合检测预测术后支架内再狭窄的价值[J].临床心血管病杂志, 2021, 37(08):714-719
[25]See Y P, Cho Y, Pascoe E M, et al.Predictors of Arteriovenous Fistula Failure: A Post Hoc Analysis of the FAVOURED Study[J].Kidney, 2020, 1(11):1259-1269
[26]Yilmaz H, Bozkurt A, Cakmak M, et al.Relationship between late arteriovenous fistula (AVF) stenosis and neutrophil-lymphocyte ratio (NLR) in chronic hemodialysis patients[J].Ren Fail, 2014, 36(9):1390-1394
